Related Experiment Video
Updated: Jun 5, 2026
09:40
Teasing Out the Interplay Between Natural Killer Cells and Nociceptor Neurons
Published on: June 30, 2022
Genomic loci and candidate genes underlying inflammatory nociception
Harsha K Nair1, Heather Hain, Raymond M Quock
1University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA VA Medical Center and Oregon Health & Science University, Portland, OR, USA Washington State University, Pullman, WA, USA The Jackson Laboratory, Bar Harbor, ME, USA.
Pain
|January 4, 2011
Summary
Genetic factors significantly influence inflammatory pain sensitivity. This study identified novel genetic regions and candidate genes associated with abdominal inflammatory pain in mice, aiding future research in humans.
Area of Science:
- Genetics
- Neuroscience
- Pain Research
Background:
- Heritable genetic factors play a substantial role in inflammatory nociception (pain).
- Understanding these genetic underpinnings is crucial for developing targeted pain therapies.
Purpose of the Study:
- To identify candidate genes responsible for inflammatory nociception.
- To map quantitative trait loci (QTLs) associated with abdominal inflammatory pain in a mouse model.
Main Methods:
- Utilized BXD recombinant inbred (RI) mouse strains for abdominal inflammatory pain assessment.
- Performed genome-wide QTL mapping on abdominal contractions and extensions following acetic acid administration.
- Analyzed microarray mRNA transcript expression profiles in conjunction with QTL data.
Main Results:
- Identified two significant QTLs on chromosomes 3 and 10, and a sex-specific QTL on chromosome 16.
- Confirmed a previously reported QTL (Nociq2) on chromosome 10 for inflammatory nociception.
- Detected covarying expression of candidate genes within QTL confidence intervals, linking gene expression to pain sensitivity.
Conclusions:
- Common and distinct genetic mechanisms contribute to heritable sensitivity to various inflammatory pain stimuli.
- Identified high-priority candidate genes for inflammatory nociception, valuable for further investigation in rodents and humans.
Related Concept Videos
01:44Nociception
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...